Beschreibung
Baseline characteristics or initial selenium status data from a New Zealand cohort study evaluating 200 micrograms/day selenium supplementation for prostate health. Stratified groups are analyzed to understand whether specific populations benefit differentially.
Cite This Figure
![Figure 1: Baseline characteristics or initial selenium status data from a New Zealand cohort study evaluating 200 micrograms/day selenium supplementation for prostate health. Stratified groups are analyzed to understand whether specific populations benefit differentially.]() > Source: Nishi Karunasinghe et al. "Selenium Supplementation and Prostate Health in a New Zealand Cohort.." *Nutrients*, 2019. PMID: [31861307](https://pubmed.ncbi.nlm.nih.gov/31861307/)
<figure> <img src="" alt="Baseline characteristics or initial selenium status data from a New Zealand cohort study evaluating 200 micrograms/day selenium supplementation for prostate health. Stratified groups are analyzed to understand whether specific populations benefit differentially." /> <figcaption>Figure 1. Baseline characteristics or initial selenium status data from a New Zealand cohort study evaluating 200 micrograms/day selenium supplementation for prostate health. Stratified groups are analyzed to understand whether specific populations benefit differentially.<br> Source: Nishi Karunasinghe et al. "Selenium Supplementation and Prostate Health in a New Zealand Cohort.." <em>Nutrients</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31861307/">31861307</a></figcaption> </figure>